MICROSCOPIC POLYANGIITIS
Clinical trials for MICROSCOPIC POLYANGIITIS explained in plain language.
Never miss a new study
Get alerted when new MICROSCOPIC POLYANGIITIS trials appear
Sign up with your email to follow new studies for MICROSCOPIC POLYANGIITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hydroxychloroquine trial for rare vasculitis halted early
Disease control TerminatedThis study tested whether adding hydroxychloroquine to standard treatments could help control ANCA vasculitis, a group of autoimmune diseases that cause inflammation of blood vessels. The trial was open to adults with certain types of vasculitis who had mild disease activity. Par…
Matched conditions: MICROSCOPIC POLYANGIITIS
Phase: PHASE4 • Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Disease control
Last updated May 26, 2026 07:00 UTC
-
Promising vasculitis drug trial halted early
Disease control TerminatedThis study tested a new drug, obinutuzumab, against the standard drug rituximab for people with a rare autoimmune disease that inflames blood vessels (ANCA-associated vasculitis). The goal was to see if obinutuzumab could better stop disease activity and clear harmful antibodies.…
Matched conditions: MICROSCOPIC POLYANGIITIS
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 13:51 UTC